Logo

06 日 マニラ

本日休刊日

両替レート
¥10,000=P3,880
$100=P5,630

06 日 マニラ

本日休刊日

両替レート
¥10,000=P3,880
$100=P5,630

FDA grants EUA to Molnarz for mild to moderate COVID-19

2021/12/24 英字

The Food and Drug Administration (FDA) has approved the emergency use authorization (EUA) for the oral COVID-19 drug Molnarz, its head announced Thursday.

Molnarz is the brand name of Molnupiravir, which is developed by Merck and Co.

FDA head Rolando Eric Domingo told the ''Laging Handa'' virtual public forum that Molnarz will be given for patients with mild to moderate COVID-19.

Molnarz should be given twice a day for five days immediately after one is diagnosed with COVID-19, said Domingo.

'' It should be given as soon as possible after diagnosis and within the first five days after the onset of symptoms,'' said Domingo. DMS

おすすめ記事

Headline inflation in June up, driven by electricity rates, higher pork prices

2025/7/5 英字 無料
無料

Effect of P50 wage hike on minimum wage earners not to be felt immediately

2025/7/5 英字 無料
無料

Bilateral parterships testament to strength of US-Philippine relations: DFA chief

2025/7/5 英字 無料
無料

Police sends two robbery cases to Makati prosecutors

2025/7/5 英字 無料
無料

Four PMA cadets to face hazing raps

2025/7/5 英字 無料
無料

''Bising'' leaves PAR, Metro Manila and other areas may experience rain

2025/7/5 英字 無料
無料